BioNTech SE (BNTX)
89.38
+1.67
(+1.90%)
USD |
NASDAQ |
Oct 19, 14:46
BioNTech Cash from Operations (Annual) : 514.63M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 514.63M |
| December 31, 2024 | 224.67M |
| December 31, 2023 | 5.807B |
| December 31, 2022 | 14.27B |
| December 31, 2021 | 1.052B |
| Date | Value |
|---|---|
| December 31, 2020 | -15.36M |
| December 31, 2019 | -222.21M |
| December 31, 2018 | -68.64M |
| December 31, 2017 | -59.29M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Biodexa Pharmaceuticals Plc | -7.268M |
| Moderna, Inc. | -1.873B |
| Mereo BioPharma Group Plc | -31.04M |
| NuCana Plc | -9.377M |
| Immatics NV | -199.34M |